Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Campylobacter jejuni/Escherichia coli oral vaccine - Immuron/Naval Medical Research Center

Next Previous
Search
Drug Profile

Campylobacter jejuni/Escherichia coli oral vaccine - Immuron/Naval Medical Research Center

Alternative Names: CampETEC; CampETEC HBC product; Campylobacter/ETEC vaccine - Immuron/Naval Medical Research Center

Latest Information Update: 09 Oct 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Immuron
  • Developer Immuron; Naval Medical Research Center
  • Class Bacterial vaccines; Escherichia coli vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Traveller's diarrhoea

Most Recent Events

  • 04 Oct 2024 Efficacy, adverse event and immunogenicity data from phase I trial in Traveller's diarrhea released by Immuron
  • 04 Dec 2023 Immuro in collaboration with Naval Medical Research Center initiates a phase I trial in Traveller's diarrhoea (Prevention, In adults) in USA (PO) (NCT06122870)
  • 08 May 2023 Immuron reports FDA removes clinical hold of Campylobacter jejuni/Escherichia coli oral vaccine in two human phase 2 trials

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top